---
title: "Accenture: Valuation Compression Creates Attractive Entry Despite Prudent Near-Term Outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279183004.md"
description: "Analyst Bryan Bergin from TD Cowen has assigned a Buy rating on Accenture, lowering the price target to $275 from $282. Despite a cautious near-term outlook due to geopolitical and macro risks, he believes the stock's valuation has compressed to attractive levels. Bergin expects only slight adjustments to revenue outlook and sees the market over-discounting concerns related to geopolitical issues and GenAI. Stifel Nicolaus also maintains a Buy rating with a $315 price target."
datetime: "2026-03-16T00:55:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279183004.md)
  - [en](https://longbridge.com/en/news/279183004.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279183004.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/279183004.md) | [繁體中文](https://longbridge.com/zh-HK/news/279183004.md)


# Accenture: Valuation Compression Creates Attractive Entry Despite Prudent Near-Term Outlook

Analyst Bryan Bergin from TD Cowen assigned a Buy rating on Accenture and decreased the price target to $275.00 from $282.00.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Bryan Bergin has given his Buy rating due to a combination of factors, even as he trims near‑term expectations in light of heightened geopolitical and macro risks. He now assumes slightly slower fiscal 2026 growth and expects Accenture may either keep its current constant‑currency revenue outlook or adjust it only marginally, reflecting prudent caution rather than a meaningful deterioration in underlying demand.

At the same time, he highlights that the stock’s valuation has compressed to levels comparable to the post‑financial‑crisis period, despite only modest estimate cuts and no identified material impact to Accenture’s pipeline so far. With shares trading well below his revised $275 price target, Bergin views the risk‑reward as attractive, concluding that the market is over‑discounting geopolitical and GenAI‑related concerns relative to Accenture’s long‑term earnings and growth profile.

In another report released on March 12, Stifel Nicolaus also maintained a Buy rating on the stock with a $315.00 price target.

### Related Stocks

- [Accenture plc (ACN.US)](https://longbridge.com/en/quote/ACN.US.md)

## Related News & Research

- [JB Capital LLC Takes Position in Accenture PLC $ACN](https://longbridge.com/en/news/281707616.md)
- [MOR Wealth Management LLC Takes $7.95 Million Position in Accenture PLC $ACN](https://longbridge.com/en/news/281009499.md)
- [Accenture Completes Acquisition of Faculty | ACN Stock News](https://longbridge.com/en/news/279223013.md)
- [Spire Wealth Management Sells 19,689 Shares of Accenture PLC $ACN](https://longbridge.com/en/news/281622484.md)
- [Donaldson Capital Management LLC Sells 8,306 Shares of Accenture PLC $ACN](https://longbridge.com/en/news/280979680.md)